Department of Pediatrics, The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Division of Infectious Diseases, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
J Antimicrob Chemother. 2020 Jan 1;75(1):1-13. doi: 10.1093/jac/dkz325.
Drug-induced nephrotoxicity is responsible for 20% to 60% of cases of acute kidney injury in hospitalized patients and is associated with increased morbidity and mortality in both children and adults. Antimicrobials are one of the most common classes of medications prescribed globally and also among the most common causes of nephrotoxicity. A broad range of antimicrobial agents have been associated with nephrotoxicity, but the features of kidney injury vary based on the agent, its mechanism of injury and the site of toxicity within the kidney. Distinguishing nephrotoxicity caused by an antimicrobial agent from other potential inciting factors is important to facilitate both early recognition of drug toxicity and prompt cessation of an offending drug, as well as to avoid unnecessary discontinuation of an innocuous therapy. This review will detail the different types of antimicrobial-induced nephrotoxicity: acute tubular necrosis, acute interstitial nephritis and obstructive nephropathy. It will also describe the mechanism of injury caused by specific antimicrobial agents and classes (vancomycin, aminoglycosides, polymyxins, antivirals, amphotericin B), highlight the toxicodynamics of these drugs and provide guidance on administration or monitoring practices that can mitigate toxicity, when known. Particular attention will be paid to paediatric patients, when applicable, in whom nephrotoxin exposure is an often-underappreciated cause of kidney injury.
药物性肾毒性导致 20%至 60%住院患者发生急性肾损伤,并且与儿童和成人的发病率和死亡率增加相关。抗生素是全球最常用的药物类别之一,也是最常见的肾毒性原因之一。广泛的抗生素与肾毒性有关,但肾脏损伤的特征因药物、其损伤机制和毒性部位而异。区分抗生素引起的肾毒性与其他潜在的诱发因素对于促进早期识别药物毒性和及时停止使用有问题的药物非常重要,同时也可以避免不必要地停止无害治疗。这篇综述将详细介绍不同类型的抗生素引起的肾毒性:急性肾小管坏死、急性间质性肾炎和梗阻性肾病。它还将描述特定抗生素和药物类别(万古霉素、氨基糖苷类、多黏菌素、抗病毒药物、两性霉素 B)引起的损伤机制,强调这些药物的毒代动力学,并在已知情况下提供减轻毒性的给药或监测实践的指导。特别关注儿科患者,因为在这些患者中,肾毒性物质暴露是经常被低估的肾脏损伤原因。